U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H30O
Molecular Weight 310.473
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DESOGESTREL

SMILES

[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]3([H])[C@@]4([H])CCCC=C4CC[C@@]23[H]

InChI

InChIKey=RPLCPCMSCLEKRS-BPIQYHPVSA-N
InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H30O
Molecular Weight 310.473
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Desogestrel is a prodrug of etonogestrel (3-keto-desogestrel) which was approved as oral contraceptove medicine. Desogestrel acts selectively binding to progesterone receptor and enchancing its activity.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
DESOGEN

Cmax

ValueDoseCo-administeredAnalytePopulation
3.69 ng/mL
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL serum
Homo sapiens
5840 pg/mL
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL plasma
Homo sapiens
2805 pg/mL
0.15 mg single, oral
ETONOGESTREL plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
35.9 ng × h/mL
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL serum
Homo sapiens
52299 pg × h/mL
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL plasma
Homo sapiens
33858 pg × h/mL
0.15 mg single, oral
ETONOGESTREL plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
23.8 h
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL serum
Homo sapiens

Funbound

ValueDoseCo-administeredAnalytePopulation
2%
0.15 mg 1 times / day steady-state, oral
ETONOGESTREL plasma
Homo sapiens
2%
0.15 mg single, oral
ETONOGESTREL plasma
Homo sapiens

Doses

AEs

Overview

CYP3A4CYP2C9CYP2D6hERG


OverviewOther

Other InhibitorOther SubstrateOther Inducer





Drug as perpetrator​

Drug as victim

PubMed

Sample Use Guides

In Vivo Use Guide
Take 1 tablet (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) at the same time every day, and at intervals not exceeding 24 hours.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
81K9V7M3A3
Record Status Validated (UNII)
Record Version